Comparison of the Folstein Mini Mental State Examination (MMSE) to the Montreal Cognitive Assessment (MoCA) as a Cognitive Screening Tool in an Inpatient Rehabilitation Setting

Aggarwal, Arun Kumar; Kean, Emma

doi:10.4236/nm.2010.12006

Cited by 86 publications

(76 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Celkové skóre v teste koreluje so skóre v Montrealskom kognitívnom teste (Montreal cognitive assessment -MoCA) (r = 0,69, resp. r s = 0,73-0,86; p < 0,001) [31][32][33] a tiež s dosiahnutým vzdelaním [34]. v ktorom u pa cientov bolo ochorenie dia gnostikované, výrazne varioval (21-78).…”

Section: Materiál a Metódyunclassified

“…Miernu kognitívnu poruchu sme zistili u 30,8 % a stredne ťažkú kognitívnu poruchu u 3,8 % participantov. miernej kognitívnej poruchy [31]. Autor škály [35] uvádza dobrú vnútornú konzistenciu škály (α = 0,83) a test-retestovú reliabilitu (r = 0,92; p < 0,001).…”

Section: Kognitívny Deficit U Pa Cientov S Hematologickou Malignitouunclassified

“…Mierny pokles v kognitívnom fungovaní u týchto jednotlivcov by mohol byť diagnostikovaný viac citlivými testami, ktoré umožňujú porovnať ich výkon s vekovo a vzdelanostne zodpovedajúcou normou. V našom výskume sme použili dva ná-stroje merania -bežne využívaný kognitívny skrín ing MMSE a test MoCA, ktorý umožňuje odhaliť kognitívny deficit aj miernej či strednej závažnosti [31]. MMSE je zameraný najmä na oblasť jazyka a pamäte a je považovaný za zlatý štandard v dia gnostike demencie.…”

Section: Záverunclassified

See 2 more Smart Citations

Cognitive Deficits in Cancer Patients with Haematological Malignancies

Mikulajová¹,

Boleková²,

Surová³

2017

Klin Onkol

View full text Add to dashboard Cite

Východiská: Kognitívne deficity sú jedným z najčastejších nepriaznivých dôsledkov liečby chemoterapiou (CHT). Závery klinických štúdií poukazujú na tzv. syndróm chemo brain, ktorého symptómy sa manifestujú najmä v oblasti exekutívnych funkcií, rýchlosti spracovania informá-cií, pamäti, pozornosti či motorického tempa. Empirická evidencia tohto závažného dôsledku CHT však v súčasnosti nie je jednoznačná. Metódy: Výskumu sa zúčastnilo 26 onkologických pa cientov s hematologickými malignitami, ktorí absolvovali liečbu CHT. Kognitívny výkon bol meraný prostredníctvom dvoch skríningových kognitívnych testov -Mini-Mental State Exam ination (MMSE) a Montrealský kognitívny test (Montreal cognitive assessment -MoCA). Výsledky: Kognitívny deficit sme prostredníctvom MMSE zistili u 34,6 % pa cientov. Avšak na základe výsledkov v teste MoCA sme identifikovali miernu alebo stredne ťažkú kognitívnu poruchu až u 80,7 % pa cientov. Najvyššiu chybovosť sme zistili v úlohách zameraných na pamäť, pozornosť, priestorovú orientáciu, exekutívne funkcie a abstrakciu. Kognitívny deficit progreduje s vekom, ale nie s dĺžkou terapie. Záver: Deficity v kognitívnych funkciách sa po absolvovaní CHT vyskytujú u nezanedbateľného množstva pa cientov, avšak ich dia gnostika závisí od citlivosti zvoleného nástroja merania. Skríningové škály poskytujú prvú informáciu o kognitívnom fungovaní pa cienta a môžu indikovať potrebu ďalšieho neuropsychologického vyšetrenia. Včasná dia gnostika znížených kognitívnych funkcií je predpokladom efektívnej psychologickej intervencie, ktorá napomáha pa cientom rýchlejšie sa vyrovnať s nežiaducimi následkami liečby CHT. Key wordschemother apy -cognitive dysfunction -chemo brain -cognitive screening -neuropsychological tests -psychology Summary Background: Cognitive deficits are one of the most common adverse effects of chemother apy (CHT). Previous reports suggest that this is due to the so-called chemo brain syndrome, the symp toms of which manifest mainly as impairments in executive functions, speed of information processing, memory, attention, and motor speed. However, empirical evidence for these manifestations is currently ambiguous. Methods: The research group consisted of 26 cancer patients with haematological malignancies who had undergone chemother apy treatment. Cognitive performance was measured by two screen ing cognitive tests, the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Test (MoCA). Results: MMSE detected cognitive deficits in 34.6% of patients whereas MoCA identified mild or moderate cognitive impairment in up to 80.7% of patients. The highest error rates were found in tasks focused on memory, attention, spatial orientation, executive functions, and abstraction. Cognitive deficit progressed with age, but not with duration of ther apy. Conclusion: Deficits in cognitive functions occur in a considerable number of patients after CHT, although the dia gnosis depends on the sensitivity of the detection method. Screen ing scales usually provide the first indication of impaired co...

show abstract

Section: Materiál a Metódyunclassified

Section: Kognitívny Deficit U Pa Cientov S Hematologickou Malignitouunclassified

Section: Záverunclassified

See 1 more Smart Citation

Cognitive Deficits in Cancer Patients with Haematological Malignancies

Mikulajová¹,

Boleková²,

Surová³

2017

Klin Onkol

View full text Add to dashboard Cite

show abstract

“…Existing norms are based on a Canadian sample (N = 90) with a mean age in the mid 70s and mean education of approximately 12 years. Although less is known about its psychometric properties, the MoCA has a potential advantage over other brief cognitive screening tests such as the 30-item Mini-Mental State Examination (MMSE) [13] and the 10-item Short Portable Mental Status Questionnaire (SPMSQ) [12] because of its greater sensitivity to more subtle cognitive impairment [14,21].…”

Section: Introductionmentioning

confidence: 99%

The relationship of montreal cognitive assessment scores to framingham coronary and stroke risk scores

Weiner¹,

Hynan²,

Rossetti³

et al. 2011

OJPsych

View full text Add to dashboard Cite

We examined the relationship between a brief cognitive screening measure and Framingham Coronary and Stroke Risk scores. We administered the Montreal Cognitive Assessment (MoCA) to participants in the Dallas Heart Study, a community-based multiethnic study investigating the development of atherosclerosis. The composition of the group was 50% African American, 36% Caucasian and 14% Hispanic. There were 765 subjects (mean age 51 years) who had both Coronary and Stroke Risk scores and an additional 144 subjects with only Coronary Risk scores available. There was a small significant inverse relationship between MoCA and Framingham Coronary and Stroke Risk scores. MoCA scores were influenced by education, but were not influenced by age or by the presence of one or more apoE4 alleles.

show abstract

“…This is a major flaw if one considers the important role of executive functions in early clinical stages of dementia 3 . Another limitation is that the MMSE has a low sensitivity for patients with mild memory deficits 5 , since only three words are required to be remembered in the recall task. Finally, MMSE does not analyze behavioral changes, which are important in Alzheimer's disease (AD) and frontotemporal dementia (FTD) diagnosis 6,7 .…”

mentioning

confidence: 99%

Philadelphia Brief Assessment of Cognition in healthy and clinical Brazilian sample

Pereira¹,

Satler²,

Medeiros³

et al. 2012

Arq. Neuro-Psiquiatr.

View full text Add to dashboard Cite

Comparison of the Folstein Mini Mental State Examination (MMSE) to the Montreal Cognitive Assessment (MoCA) as a Cognitive Screening Tool in an Inpatient Rehabilitation Setting

Abstract: Identifying the presence of cognitive impairment in patients admitted for inpatient rehabilitation is important as it may

Cited by 86 publications

References 9 publications

Cognitive Deficits in Cancer Patients with Haematological Malignancies

Cognitive Deficits in Cancer Patients with Haematological Malignancies

The relationship of montreal cognitive assessment scores to framingham coronary and stroke risk scores

Philadelphia Brief Assessment of Cognition in healthy and clinical Brazilian sample

Contact Info

Product

Resources

About